Y-Mabs Therapeutics, Inc. (YMAB)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

($1.34M) Net Amount

Buy:	0	--
Sell:	($1.34M)	$12.97 - $14.69

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

1

(3)

1

(2)

0

(1)

17

0

0

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Aug-24 5:05 PM View:	26-Aug-24 Market Sale ($73.45K)	Wilms Joris SVP & CHIEF OPERATING OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	(14%) 35.6K to 30.6K	0	($73.45K) (14%)	--	$14.69	Show Txns Hide Txns

30-Aug-24 4:15 PM View:	28-Aug-24 Option Sale ($768.50K)	Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	0% 81.26K	0	0	--	--	Show Txns Hide Txns

20-Sep-24 4:15 PM View:	19-Sep-24 Option Exercise $100.00K	Gad Thomas Chief Business Officer Director		Y-Mabs Therapeutics, Inc. - YMAB	(19%) 381.38K to 309.21K	0	($1.26M) (25%)	--	$12.97 - $13.47	Show Txns Hide Txns